8-K: Quantum Computing Inc. Secures $200 Million Private Placement to Fuel Commercialization and Strategic Growth

Quantum Computing Inc. (QCi) successfully closed a $200 million private placement of common stock, significantly bolstering its cash reserves to over $350 million for accelerated commercialization and strategic acquisitions.

Summary

• Quantum Computing Inc. (QCi) entered into securities purchase agreements on June 22, 2025, for a private placement of 14,035,089 shares of common stock at a purchase price of $14.25 per share.
• The closing of the private placement occurred on June 24, 2025, resulting in gross proceeds of approximately $200 million before deducting placement agent commissions and other offering expenses.
• Following the closing, QCi's total cash and cash equivalents are expected to exceed $350 million, and the company reports having no debt.
• Net proceeds from the offering are intended to accelerate commercialization efforts, fund strategic acquisitions, and support general working capital purposes.
• Titan Partners Group LLC acted as the sole placement agent, receiving a tiered cash fee (6% up to $100M, 5.75% up to $150M, 5.5% above $150M) and reimbursement for up to $100,000 in fees and expenses.
• Company directors and executive officers have agreed to a 60-day lock-up period on their common stock holdings following the closing date of the Placement.

Sentiment

Score: 8

Explanation: The successful completion of a significant private placement, raising $200 million and boosting cash reserves to over $350 million with no debt, is a strong positive. It demonstrates investor confidence and provides substantial capital for strategic growth initiatives, despite past minor compliance issues which have been remediated.

Positives

• Successfully raised $200 million in gross proceeds through a private placement, demonstrating strong investor confidence.
• Attracted support from several preeminent global institutional investment firms, validating QCi's long-term vision and technology.
• Significantly strengthened the company's financial position, with total cash and cash equivalents now exceeding $350 million and no debt.
• The capital infusion provides substantial financial resources to fund the product roadmap, accelerate commercialization efforts, and pursue strategic acquisitions.

Negatives

• The company has a history of Nasdaq listing compliance issues, including late Form 10-Q filings in June 2024 (since remediated in October 2024) and a stock price falling below $1.00 in November 2023 (since remediated in March 2024).
• Insurance renewal may result in a significant increase in cost, which could impact future profitability.
• Placement agent commissions and other offering expenses will reduce the net proceeds received from the $200 million gross raise.

Risks

• Forward-looking statements are subject to inherent risks and uncertainties, including the timing of orders and revenue, and the outcome of ongoing collaborations and demonstration projects with government agencies, academic institutions, and commercial customers.
• Purchaser trading activities, including short sales or derivative transactions, could negatively impact the market price of the company's publicly traded securities.
• The company's ability to maintain compliance with Nasdaq listing rules, particularly regarding bid price and timely filings, remains a historical concern, despite recent remediation.
• Potential for a Material Adverse Effect on the business, general affairs, management, financial condition, results of operations, shareholders' equity, properties, or prospects of the company and its subsidiaries.
• Insurance coverage renewal may lead to significantly increased costs, impacting operational expenses.

Future Outlook

The company intends to use the net proceeds from the private placement to accelerate commercialization efforts, pursue strategic acquisitions, and for general corporate purposes. Management expresses confidence in the company's strategy, market potential, and differentiated technology platform, indicating a focus on growth and expansion in the quantum and photonic technologies sector.

Management Comments

• "We're encouraged by the strong interest and support from major institutional investors who share our long-term vision for quantum and photonic technologies." Dr. Yuping Huang, Interim CEO of QCi.
• "This capital raise reflects growing confidence in QCi's strategy, market potential, and differentiated technology platform." Dr. Yuping Huang, Interim CEO of QCi.
• "Following the successful close of this offering, we now have over $350 million in cash and cash equivalents and no debt." Chris Roberts, Chief Financial Officer of QCi.
• "This provides us with additional financial resources to fund our product roadmap, accelerate commercialization, and pursue strategic opportunities for our quantum machines and thin-film lithium niobate foundry services." Chris Roberts, Chief Financial Officer of QCi.

Industry Context

Quantum Computing Inc. operates at the forefront of integrated photonics and quantum optics, developing accessible and affordable quantum machines and providing foundry services for thin-film lithium niobate (TFLN) photonic chips. This successful capital raise positions QCi to accelerate its efforts in high-performance computing, artificial intelligence, cybersecurity, and remote sensing applications, all of which are rapidly evolving and capital-intensive sectors. The strong institutional investor interest suggests a positive market perception of QCi's differentiated technology platform within this high-growth industry.

Corporate Governance

Legal Proceedings

• No new legal proceedings are disclosed. The company represents that there are no pending or threatened actions that would result in a Material Adverse Effect, except as may be detailed in undisclosed schedules.
• No director or officer has been the subject of any action involving a claim of violation of federal or state securities laws or breach of fiduciary duty.
• The Commission has not issued any stop order suspending the effectiveness of any registration statement filed by the company.

Stakeholder Impact

• **Shareholders**: Experience dilution from the issuance of new shares but benefit from enhanced financial stability, reduced debt risk, and funding for future growth and strategic initiatives. However, hedging activities by purchasers could negatively impact the market price.
• **Employees**: Potential for increased job security and growth opportunities due to accelerated commercialization and strategic acquisitions funded by the capital raise.
• **Customers**: Potential for improved products and services as the company accelerates its product roadmap and commercialization efforts with the new capital.
• **Creditors**: Improved creditworthiness due to a significantly strengthened cash position and the absence of debt.

Next Steps

• File a registration statement for the resale of the Placement Shares by July 9, 2025.
• Maintain the listing or quotation of the Common Stock on each Trading Market.
• Continue to fund the product roadmap, accelerate commercialization efforts, and pursue strategic opportunities.

Key Dates

Recommendation

Keywords

Quantum Computing, Photonics, Quantum Optics, Private Placement, Capital Raise, Common Stock, Nasdaq, QUBT, Thin-Film Lithium Niobate, TFLN, Artificial Intelligence, Cybersecurity, High-Performance Computing, Strategic Acquisitions, Commercialization